Correlation Between Berkshire Hathaway and Knight Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Berkshire Hathaway and Knight Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Berkshire Hathaway and Knight Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Berkshire Hathaway CDR and Knight Therapeutics, you can compare the effects of market volatilities on Berkshire Hathaway and Knight Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Berkshire Hathaway with a short position of Knight Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Berkshire Hathaway and Knight Therapeutics.

Diversification Opportunities for Berkshire Hathaway and Knight Therapeutics

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Berkshire and Knight is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Berkshire Hathaway CDR and Knight Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Knight Therapeutics and Berkshire Hathaway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Berkshire Hathaway CDR are associated (or correlated) with Knight Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Knight Therapeutics has no effect on the direction of Berkshire Hathaway i.e., Berkshire Hathaway and Knight Therapeutics go up and down completely randomly.

Pair Corralation between Berkshire Hathaway and Knight Therapeutics

Assuming the 90 days trading horizon Berkshire Hathaway CDR is expected to generate 0.59 times more return on investment than Knight Therapeutics. However, Berkshire Hathaway CDR is 1.7 times less risky than Knight Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Knight Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  2,405  in Berkshire Hathaway CDR on November 27, 2024 and sell it today you would earn a total of  1,360  from holding Berkshire Hathaway CDR or generate 56.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Berkshire Hathaway CDR  vs.  Knight Therapeutics

 Performance 
       Timeline  
Berkshire Hathaway CDR 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Berkshire Hathaway CDR are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Berkshire Hathaway is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Knight Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Knight Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Knight Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Berkshire Hathaway and Knight Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Berkshire Hathaway and Knight Therapeutics

The main advantage of trading using opposite Berkshire Hathaway and Knight Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Berkshire Hathaway position performs unexpectedly, Knight Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Knight Therapeutics will offset losses from the drop in Knight Therapeutics' long position.
The idea behind Berkshire Hathaway CDR and Knight Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios